Global Cancer (Tumor) Profiling Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • receipt Report ID : 151944
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 121
  • list Pharmaceuticals and Healthcare

The cancer/tumor profiling market in terms of technology has been segmented into next generation sequencing (NGS), quantitative polymerase chain reaction (QPCR), immunohistochemistry (IHC), in-situ hybridization (ISH), and microarray, based on technology.

Scope of the Report:

Europe held the second largest share of 27.7% in the global cancer/tumor profiling market in 2017.

The worldwide market for Cancer (Tumor) Profiling is expected to grow at a CAGR of roughly 11.0% over the next five years, will reach 9830 million US$ in 2023, from 5260 million US$ in 2017, according to a new GIR (Global Info Research) study.

This report focuses on the Cancer (Tumor) Profiling in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers

Illumina, Inc.

Qiagen N.V.

Neogenomics Laboratories, Inc.

HTG Molecular Diagnostics, Inc.

Genomic Health Inc.

Caris Life Sciences

Helomics Corporation

Nanostring Technologies, Inc.

Oxford Gene Technology

Ribomed Biotechnologies, Inc.

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Immunoassay

Hybridization

NGS

Mass Spectrometry

Market Segment by Applications, can be divided into

Clinical

Research

There are 15 Chapters to deeply display the global Cancer (Tumor) Profiling market.

Chapter 1, to describe Cancer (Tumor) Profiling Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Cancer (Tumor) Profiling, with sales, revenue, and price of Cancer (Tumor) Profiling, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Cancer (Tumor) Profiling, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Cancer (Tumor) Profiling market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Cancer (Tumor) Profiling sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Market Overview

1.1 Cancer (Tumor) Profiling Introduction

1.2 Market Analysis by Type

1.2.1 Immunoassay

1.2.2 Hybridization

1.2.3 NGS

1.2.4 Mass Spectrometry

1.3 Market Analysis by Applications

1.3.1 Clinical

1.3.2 Research

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Illumina, Inc.

2.1.1 Business Overview

2.1.2 Cancer (Tumor) Profiling Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Illumina, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 Qiagen N.V.

2.2.1 Business Overview

2.2.2 Cancer (Tumor) Profiling Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Qiagen N.V. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Neogenomics Laboratories, Inc.

2.3.1 Business Overview

2.3.2 Cancer (Tumor) Profiling Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Neogenomics Laboratories, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 HTG Molecular Diagnostics, Inc.

2.4.1 Business Overview

2.4.2 Cancer (Tumor) Profiling Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 HTG Molecular Diagnostics, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Genomic Health Inc.

2.5.1 Business Overview

2.5.2 Cancer (Tumor) Profiling Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Genomic Health Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 Caris Life Sciences

2.6.1 Business Overview

2.6.2 Cancer (Tumor) Profiling Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Caris Life Sciences Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Helomics Corporation

2.7.1 Business Overview

2.7.2 Cancer (Tumor) Profiling Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Helomics Corporation Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Nanostring Technologies, Inc.

2.8.1 Business Overview

2.8.2 Cancer (Tumor) Profiling Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Nanostring Technologies, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Oxford Gene Technology

2.9.1 Business Overview

2.9.2 Cancer (Tumor) Profiling Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Oxford Gene Technology Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Ribomed Biotechnologies, Inc.

2.10.1 Business Overview

2.10.2 Cancer (Tumor) Profiling Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Ribomed Biotechnologies, Inc. Cancer (Tumor) Profiling Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Cancer (Tumor) Profiling Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Cancer (Tumor) Profiling Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Cancer (Tumor) Profiling Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Cancer (Tumor) Profiling Manufacturer Market Share in 2017

3.3.2 Top 6 Cancer (Tumor) Profiling Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Cancer (Tumor) Profiling Market Analysis by Regions

4.1 Global Cancer (Tumor) Profiling Sales, Revenue and Market Share by Regions

4.1.1 Global Cancer (Tumor) Profiling Sales and Market Share by Regions (2013-2018)

4.1.2 Global Cancer (Tumor) Profiling Revenue and Market Share by Regions (2013-2018)

4.2 North America Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

4.3 Europe Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

4.5 South America Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

5 North America Cancer (Tumor) Profiling by Countries

5.1 North America Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries

5.1.1 North America Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)

5.1.2 North America Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)

5.2 United States Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

5.3 Canada Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

5.4 Mexico Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

6 Europe Cancer (Tumor) Profiling by Countries

6.1 Europe Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries

6.1.1 Europe Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)

6.2 Germany Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

6.3 UK Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

6.4 France Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

6.5 Russia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

6.6 Italy Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

7 Asia-Pacific Cancer (Tumor) Profiling by Countries

7.1 Asia-Pacific Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)

7.2 China Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

7.3 Japan Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

7.4 Korea Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

7.5 India Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

8 South America Cancer (Tumor) Profiling by Countries

8.1 South America Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries

8.1.1 South America Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)

8.1.2 South America Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

8.3 Argentina Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

8.4 Colombia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

9 Middle East and Africa Cancer (Tumor) Profiling by Countries

9.1 Middle East and Africa Cancer (Tumor) Profiling Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Cancer (Tumor) Profiling Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Cancer (Tumor) Profiling Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

9.3 UAE Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

9.4 Egypt Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

9.5 Nigeria Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

9.6 South Africa Cancer (Tumor) Profiling Sales and Growth Rate (2013-2018)

10 Global Cancer (Tumor) Profiling Market Segment by Type

10.1 Global Cancer (Tumor) Profiling Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Cancer (Tumor) Profiling Sales and Market Share by Type (2013-2018)

10.1.2 Global Cancer (Tumor) Profiling Revenue and Market Share by Type (2013-2018)

10.2 Immunoassay Sales Growth and Price

10.2.1 Global Immunoassay Sales Growth (2013-2018)

10.2.2 Global Immunoassay Price (2013-2018)

10.3 Hybridization Sales Growth and Price

10.3.1 Global Hybridization Sales Growth (2013-2018)

10.3.2 Global Hybridization Price (2013-2018)

10.4 NGS Sales Growth and Price

10.4.1 Global NGS Sales Growth (2013-2018)

10.4.2 Global NGS Price (2013-2018)

10.5 Mass Spectrometry Sales Growth and Price

10.5.1 Global Mass Spectrometry Sales Growth (2013-2018)

10.5.2 Global Mass Spectrometry Price (2013-2018)

11 Global Cancer (Tumor) Profiling Market Segment by Application

11.1 Global Cancer (Tumor) Profiling Sales Market Share by Application (2013-2018)

11.2 Clinical Sales Growth (2013-2018)

11.3 Research Sales Growth (2013-2018)

12 Cancer (Tumor) Profiling Market Forecast (2018-2023)

12.1 Global Cancer (Tumor) Profiling Sales, Revenue and Growth Rate (2018-2023)

12.2 Cancer (Tumor) Profiling Market Forecast by Regions (2018-2023)

12.2.1 North America Cancer (Tumor) Profiling Market Forecast (2018-2023)

12.2.2 Europe Cancer (Tumor) Profiling Market Forecast (2018-2023)

12.2.3 Asia-Pacific Cancer (Tumor) Profiling Market Forecast (2018-2023)

12.2.4 South America Cancer (Tumor) Profiling Market Forecast (2018-2023)

12.2.5 Middle East and Africa Cancer (Tumor) Profiling Market Forecast (2018-2023)

12.3 Cancer (Tumor) Profiling Market Forecast by Type (2018-2023)

12.3.1 Global Cancer (Tumor) Profiling Sales Forecast by Type (2018-2023)

12.3.2 Global Cancer (Tumor) Profiling Market Share Forecast by Type (2018-2023)

12.4 Cancer (Tumor) Profiling Market Forecast by Application (2018-2023)

12.4.1 Global Cancer (Tumor) Profiling Sales Forecast by Application (2018-2023)

12.4.2 Global Cancer (Tumor) Profiling Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Cancer (Tumor) Profiling Picture

Table Product Specifications of Cancer (Tumor) Profiling

Figure Global Sales Market Share of Cancer (Tumor) Profiling by Types in 20

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery